Aspen Pharmacare Holdings Limited
APNHYOTCHealthcare● Active
$9.03
+$0.16(+1.80%)
Market Cap$4.0B
P/E Ratio—
52W High$9.03
52W Low$5.24
Aspen Pharmacare Holdings Limited (APNHY) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
APNHY · earnings · updated Jun 8, 2026
Latest Earnings
Q1 FY2026Report Date: Mar 3, 2026EPS Actual
$0.19
Revenue
$0.98B
Est. $0.98B · +0.0%
Fiscal Period
Q1 FY2026
FY ends December
Report Date
Mar 3, 2026
After Market Close
APNHY reports quarterly as a OTC-listed Drug Manufacturers - Specialty & Generic company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
$0.21
Rev. $0.66B
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.$0.21
Rev. Est.$0.66B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Sep 2, 2026 | — | — | — | — | — | — |
| — Q1 FY2026 | Mar 3, 2026 | — | $0.19 | — | $0.98B | $0.98B | +0.0% |
| — Q3 FY2025 | Sep 1, 2025 | — | -$0.44 | — | $1.20B | — | — |
| — Q1 FY2025 | Mar 3, 2025 | — | $0.28 | — | $1.16B | — | — |
| ▼ Q3 FY2024 | Sep 3, 2024 | $0.57 | $0.26 | -54.4% | $1.30B | $1.30B | +0.0% |
| — Q1 FY2024 | Mar 14, 2024 | — | $0.28 | — | $1.15B | $1.06B | +8.9% |
| ▼ Q2 FY2023 | Jun 30, 2023 | $0.48 | $0.31 | -35.7% | $1.15B | $1.17B | -1.7% |
| — Q4 FY2022 | Dec 31, 2022 | — | $0.36 | — | $1.13B | — | — |
Q3 FY2026
Sep 2, 2026
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q1 FY2026
Mar 3, 2026
EPS Actual
$0.19
EPS Est.
—
EPS Surpr.
—
Revenue
$0.98B
Q3 FY2025
Sep 1, 2025
EPS Actual
-$0.44
EPS Est.
—
EPS Surpr.
—
Revenue
$1.20B
Q1 FY2025
Mar 3, 2025
EPS Actual
$0.28
EPS Est.
—
EPS Surpr.
—
Revenue
$1.16B
Q3 FY2024
Sep 3, 2024Miss
EPS Actual
$0.26
EPS Est.
$0.57
EPS Surpr.
-54.4%
Revenue
$1.30B
Q1 FY2024
Mar 14, 2024
EPS Actual
$0.28
EPS Est.
—
EPS Surpr.
—
Revenue
$1.15B
Q2 FY2023
Jun 30, 2023Miss
EPS Actual
$0.31
EPS Est.
$0.48
EPS Surpr.
-35.7%
Revenue
$1.15B
Q4 FY2022
Dec 31, 2022
EPS Actual
$0.36
EPS Est.
—
EPS Surpr.
—
Revenue
$1.13B
Analyst Estimates
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2025 | $0.00 | $0.00 | $0.00 | 0 |
| Q3 FY2025 | $0.00 | $0.00 | $0.00 | 0 |
| Q2 FY2025 | $0.00 | $0.00 | $0.00 | 0 |
| Q2 FY2024 | $0.00 | $0.00 | $0.00 | 0 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2025 | $16.3B | $16.3B | $16.3B | 1 |
| Q3 FY2025 | $21.6B | $21.6B | $21.6B | 1 |
| Q2 FY2025 | $21.4B | $21.4B | $21.4B | 1 |
| Q2 FY2024 | $22.7B | $22.7B | $22.7B | 1 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| — Q1 FY2026 | Mar 3, 2026 | — | $8.34 | $8.33 | -0.12% |
| — Q3 FY2025 | Sep 1, 2025 | — | $6.01 | $5.75 | -4.33% |
| — Q1 FY2025 | Mar 3, 2025 | — | $9.12 | $9.92 | +8.77% |
| ▼ Q3 FY2024 | Sep 3, 2024 | -54.4% | $13.49 | $11.35 | -15.86% |
| — Q1 FY2024 | Mar 14, 2024 | — | $10.92 | $11.19 | +2.47% |
| ▼ Q2 FY2023 | Jun 30, 2023 | -35.7% | $9.77 | $9.77 | +0.00% |
| — Q4 FY2022 | Dec 31, 2022 | — | $8.03 | $8.10 | +0.87% |
| ▼ Q2 FY2022 | Jun 30, 2022 | -11.0% | $8.99 | $8.99 | +0.00% |
Q1 FY2026-0.12%
Report Date
Mar 3, 2026
EPS Beat/Miss
—
Price Before
$8.34
Price After
$8.33
Q3 FY2025-4.33%
Report Date
Sep 1, 2025
EPS Beat/Miss
—
Price Before
$6.01
Price After
$5.75
Q1 FY2025+8.77%
Report Date
Mar 3, 2025
EPS Beat/Miss
—
Price Before
$9.12
Price After
$9.92
Q3 FY2024-15.86%
Report Date
Sep 3, 2024
EPS Beat/Miss
-54.4%
Price Before
$13.49
Price After
$11.35
Q1 FY2024+2.47%
Report Date
Mar 14, 2024
EPS Beat/Miss
—
Price Before
$10.92
Price After
$11.19
Q2 FY2023+0.00%
Report Date
Jun 30, 2023
EPS Beat/Miss
-35.7%
Price Before
$9.77
Price After
$9.77
Q4 FY2022+0.87%
Report Date
Dec 31, 2022
EPS Beat/Miss
—
Price Before
$8.03
Price After
$8.10
Q2 FY2022+0.00%
Report Date
Jun 30, 2022
EPS Beat/Miss
-11.0%
Price Before
$8.99
Price After
$8.99
Avg Miss Reaction-5.29%
Beat Rate0 / 8 quarters
Largest Move-15.86% (Q3 FY2024)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: APNHY ends December
Aspen Pharmacare Holdings Limited (APNHY) most recently reported earnings on March 3, 2026 for Q1 FY2026, posting EPS of $0.19 (in line with the analyst consensus of —). The next APNHY earnings date is expected around September 1, 2026.
Each quarter, investors track APNHY earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. APNHY revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
APNHY's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
APNHY earnings · 4 questionsAspen Pharmacare Holdings Limited's next earnings report is expected around September 1, 2026. APNHY typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; APNHY historically reports after market close (AMC).
APNHY earnings datewhen is APNHY earningsAPNHY next earnings datewhen does APNHY report earningsAPNHY earnings calendar
▸ Source: FMP · Aspen Pharmacare Holdings Limited SEC filings · US GAAP · Aspen Pharmacare Holdings Limited SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026